Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC
Clinical trial NCT03525782 · UNKNOWN
Trial details
- NCT number
- NCT03525782
- Sponsor
- The First Affiliated Hospital of Guangdong Pharmaceutical University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-01
- Primary completion
- 2021-01-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.